SCHEMBL23769070

SCHEMBL23769070

O=C(Nc1ccc2c(c1)N(Cc1noc3ccccc13)C(=O)CS2)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.43
MAPK1 P28482 6/20 0.43
HTT P42858 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
USP2 O75604 3/20 0.43
TP53 P04637 2/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
RAB9A P51151 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALOX15 P16050 1/20 0.41
CFTR P13569 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25035503 0.87 STING1 (0.44) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL23768795 0.83 MAPT (0.49) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL29978870 0.83 MAPT (0.49) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL25138405 0.78 MAPT (0.45) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL29979471 0.78 MAPT (0.45) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL29978714 0.78 MAPK1 (0.49) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL23769075 0.78 MAPK1 (0.49) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL23769076 0.77 MAPT (0.49) MAPTMAPK1HTTSMN1; SMN2USP2
SCHEMBL25028539 0.77 MAPT (0.49) MAPTMAPK1SMN1; SMN2USP2TP53
SCHEMBL30248606 0.77 MAPT (0.49) MAPTMAPK1SMN1; SMN2USP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 CN claimed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS MAPT 3716/4885MAPK1 2469/4885HTT 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.